Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement

Activity ID

3694

Expires

August 20, 2022

Format Type

Enduring

CME Credit

0.5

Fee

$30

CME Provider

JAMA

Description

Interview with Carol M Mangione, MD MSPH, USPSTF member and coauthor of Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation StatementAudio at 5:55 was changed to reflect a revised risk increase statement.

Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

ABMS Member Board Approvals by Type

ABMS MOC Part II CME Activity

Allergy and Immunology

Anesthesiology

Colon and Rectal Surgery

Family Medicine

Medical Genetics and Genomics

Nuclear Medicine

Ophthalmology

Orthopaedic Surgery

Pathology

Physical Medicine and Rehabilitation

Plastic Surgery

Preventive Medicine

Psychiatry and Neurology

Radiology

Thoracic Surgery

Urology

More Information

Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

General Information

Educational Objectives

To review the US Preventive Services Task Force (USPSTF) recommendations regarding risk assessment, genetic counseling, and genetic testing for BRCA-related cancer.

Keywords

Breast Cancer, Cancer Genetics, Cancer Screening, Prevention, Control, Genetics and Genomics, Guidelines

Competencies

Medical Knowledge, Patient Care & Procedural Skills

CME Credit Type

AMA PRA Category 1 Credit